Aditxt, Inc.ADTXEarnings & Financial Report
Nasdaq · Health Care · Pharmaceutical Preparations
Aditxt, Inc. is a clinical-stage biotechnology company focused on immunology. It develops targeted therapies to promote immune tolerance for patients with autoimmune diseases and organ transplant recipients, plus immune monitoring technologies. Its main markets are in North America, with expansion efforts underway in other global developed healthcare regions.
Top Holders
| Holder | % Owned | Shares | Change | As of |
|---|---|---|---|---|
| Mitchell | 1.50% | 6.9K | — | 2024-02-06 |
| CVI Investments, Inc. | 0.50% | 2.1K | — | 2024-02-14 |
| Sabby Volatility Warrant Master Fund, Ltd. | — | 22.0K | — | 2024-01-02 |
Insider Transactions
Net 90d: +$20.5K · buys $24.1K / sells $3.6KRange:
Action:
Role:
| Insider | Role | Action | ||||
|---|---|---|---|---|---|---|
| 2026-04-22 | HRT FINANCIAL LP | 10% Owner | Sell (open market) | 12.0K | $0.30 | $3.6K |
| 2026-04-21 | HRT FINANCIAL LP | 10% Owner | Buy (open market) | 72.9K | $0.33 | $24.1K |
1–2 of 2